Symbol="XCUR"
AssetType="Common Stock"
Name="Exicure Inc"
Description="Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois."
CIK="1698530"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8045 LAMON AVE, SUITE 410, SKOKIE, IL, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6935900"
EBITDA="4257000"
PERatio="0.433"
PEGRatio="None"
BookValue="1.122"
DividendPerShare="0"
DividendYield="0"
EPS="1.85"
RevenuePerShareTTM="3.857"
ProfitMargin="0.129"
OperatingMarginTTM="0.135"
ReturnOnAssetsTTM="0.0736"
ReturnOnEquityTTM="0.564"
RevenueTTM="23790000"
GrossProfitTTM="9059000"
DilutedEPSTTM="1.85"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="9.28"
AnalystTargetPrice="2"
TrailingPE="0.433"
ForwardPE="-"
PriceToSalesRatioTTM="0.422"
PriceToBookRatio="4.852"
EVToRevenue="21.97"
EVToEBITDA="0.126"
Beta="1.131"
num_52WeekHigh="2.17"
num_52WeekLow="0.63"
num_50DayMovingAverage="1.047"
num_200DayMovingAverage="1.089"
SharesOutstanding="8648300"
DividendDate="None"
ExDividendDate="None"
symbol="XCUR"
open="0.85"
high="0.98"
low="0.85"
price="0.93"
volume="43767.00"
latest_trading_day="2023-08-30"
previous_close="0.85"
change="0.08"
change_percent="9.4354%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="37"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="63"
Volume_recent_avg="30470"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-1.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="1137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0170.jpeg"
image_negative_thumbnail_id_2="1124"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0157.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="528"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_positive_thumbnail_id_1="1003"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
